Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement
- PMID: 22928170
- DOI: 10.7326/0003-4819-157-8-201210160-00533
Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement
Abstract
Description: New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD).
Methods: The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment.
Population: This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.
Recommendation: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement).
Similar articles
-
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2014 Mar 18;160(6):414-20. doi: 10.7326/M13-2905. Ann Intern Med. 2014. PMID: 24424622
-
Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2013 Sep 3;159(5):342-8. doi: 10.7326/0003-4819-159-5-201309030-00008. Ann Intern Med. 2013. PMID: 24026320
-
Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2015 May 5;162(9):641-50. doi: 10.7326/M15-0483. Ann Intern Med. 2015. PMID: 25798805
-
Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.Pediatrics. 2013 Nov;132(5):907-14. doi: 10.1542/peds.2013-2864. Epub 2013 Oct 7. Pediatrics. 2013. PMID: 24101758 Review.
-
Primary Care of the Patient with Chronic Kidney Disease.Med Clin North Am. 2015 Sep;99(5):935-52. doi: 10.1016/j.mcna.2015.05.003. Med Clin North Am. 2015. PMID: 26320040 Review.
Cited by
-
Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3. doi: 10.1053/j.ajkd.2013.01.006. Am J Kidney Dis. 2013. PMID: 23507265 Free PMC article. No abstract available.
-
A Novel and Noninvasive Risk Assessment Score and Its Child-to-Adult Trajectories to Screen Subclinical Renal Damage in Middle Age.Bioengineering (Basel). 2023 Feb 15;10(2):257. doi: 10.3390/bioengineering10020257. Bioengineering (Basel). 2023. PMID: 36829751 Free PMC article.
-
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?J Nephrol. 2022 Jul;35(6):1605-1618. doi: 10.1007/s40620-022-01336-7. Epub 2022 May 18. J Nephrol. 2022. PMID: 35583597 Free PMC article. Review.
-
Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.Can J Kidney Health Dis. 2018 Jun 12;5:2054358118778573. doi: 10.1177/2054358118778573. eCollection 2018. Can J Kidney Health Dis. 2018. PMID: 29977584 Free PMC article.
-
Examining chronic kidney disease screening frequency among diabetics: a POMDP approach.Health Care Manag Sci. 2024 Sep;27(3):391-414. doi: 10.1007/s10729-024-09677-4. Epub 2024 Jun 5. Health Care Manag Sci. 2024. PMID: 38836923 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical